Kallmann's syndrome:: A comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations

被引:83
|
作者
Salenave, Sylvie [1 ,2 ]
Chanson, Philippe [1 ,2 ,4 ]
Bry, Helene [1 ,2 ]
Pugeat, Michel [5 ]
Cabrol, Sylvie [6 ]
Carel, Jean Claude [2 ,7 ]
Murat, Arnaud [8 ]
Lecomte, Pierre [9 ]
Brailly, Sylvie [3 ,4 ]
Hardelin, Jean-Pierre [10 ]
Dode, Catherine [11 ]
Young, Jacques [1 ,2 ,4 ]
机构
[1] Hop Bicetre, Serv Endocrinol & Malad Reprod, AP HP, Le Kremlin Bicetre, France
[2] Ctr Reference Malad Endocriniennes Rares Croissan, F-94275 Le Kremlin Bicetre, France
[3] Univ Paris 11, Lab Genet Mol Pharmacogenet & Hormonol, F-94275 Le Kremlin Bicetre, France
[4] INSERM, U693, F-94275 Le Kremlin Bicetre, France
[5] Hop Neurol, Federat Endocrinol, F-69500 Bron, France
[6] Hop Trousseau, AP HP, Lab Explorat Fonctionnelles Endocriniennes, F-75012 Paris, France
[7] Hop Robert Debre, AP HP, Serv Endocrinol Pediat, F-75935 Paris, France
[8] CHU Nantes, Serv Endocrinol, F-44000 Nantes, France
[9] CHU Tours, Serv Endocrinol, F-37044 Tours, France
[10] Inst Pasteur, Unite Genet Deficits Sensoriels, F-75724 Paris, France
[11] Hop Cochin, AP HP, Lab Biochim & Genet Mol, F-75014 Paris, France
来源
关键词
D O I
10.1210/jc.2007-1168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Kallmann's syndrome (KS) is a genetically heterogeneous disorder consisting of congenital hypogonadotropic hypogonadism (CHH) with anosmia or hyposmia. Objective: Our objective was to compare the reproductive phenotypes of men harboring KAL1 and FGFR1/KAL2 mutations. Design and Patients: We studied the endocrine features reflecting gonadotropic-testicular axis function in 39 men; 21 had mutations in KAL1 and 18 in FGFR1/KAL2, but none had additional mutations in PROK-2 or PROKR-2 genes. Results: Puberty failed to occur in the patients with KAL1 mutations, all of whom had complete CHH. Three patients with FGFR1/KAL2 mutations had normal puberty, were eugonadal, and had normal testosterone and gonadotropin levels. Cryptorchidism was more frequent ( 14 of 21 vs. 3 of 15; P < 00.1) and testicular volume (2.4 +/- 1.1 vs. 5.4 +/- 2.4 ml; P < 0.001) was smaller in CHH subjects with KAL1 mutations than in subjects with FGFR1/KAL2 mutations. The mean basal plasma FSH level (0.72 +/- 0.47 vs. 1.48 +/- 0.62 IU/liter; P < 0.05), serum inhibin B level (19.3 +/- 10.6 vs. 39.5 +/- 19.3 pg/ml; P < 0.005), basal LH plasma level (0.57 +/- 0.54 vs. 1.0 +/- 0.6 IU/liter; P < 0.01), and GnRH-stimulated LH plasma level (1.2 +/- 1.0 vs. 4.1 +/- 3.5 IU/liter; P < 0.01) were significantly lower in the subjects with KAL1 mutations. LH pulsatility was studied in 13 CHH subjects with KAL1 mutations and seven subjects with FGFR1/KAL2 mutations; LH secretion was nonpulsatile in all the subjects, but mean LH levels were lower in those with KAL1 mutations. Conclusion: KAL1 mutations result in a more severe reproductive phenotype than FGFR1/KAL2 mutations. The latter are associated with a broader spectrum of pubertal development and with less severe impairment of gonadotropin secretion.
引用
收藏
页码:758 / 763
页数:6
相关论文
共 50 条
  • [11] A novel mutation of the KAL1 gene in monozygotic twins with Kallmann syndrome
    Matsuo, T
    Okamoto, S
    Izumi, Y
    Hosokawa, A
    Takegawa, T
    Fukui, H
    Tun, Z
    Honda, K
    Matoba, R
    Tatsumi, K
    Amino, N
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (06) : 783 - 787
  • [12] The Complex Genetics of Kallmann Syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin, J. -P.
    Dode, C.
    SEXUAL DEVELOPMENT, 2008, 2 (4-5) : 181 - 193
  • [13] A novel interstitial deletion of KAL1 in a Japanese family with Kallmann syndrome
    K. Nagata
    T. Yamamoto
    H. Chikumi
    T. Ikeda
    H. Yamamoto
    K. Hashimoto
    K. Yoneda
    E. Nanba
    H. Ninomiya
    K. Ishitobi
    Journal of Human Genetics, 2000, 45 : 237 - 240
  • [14] FGFR1 Mutations in Kallmann Syndrome
    Villanueva, C.
    de Roux, N.
    KALLMANN SYNDROME AND HYPOGONADOTROPIC HYPOGONADISM, 2010, 39 : 51 - 61
  • [15] Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome
    Georgopoulos, Neoklis A.
    Koika, Vasiliki
    Galli-Tsinopoulou, Assimina
    Spiliotis, Bessie E.
    Adonakis, George
    Keramida, Maria K.
    Sgourou, Argyro
    Koufogiannis, Kleanthis D.
    Papachatzopoulou, Adamantia
    Papavassiliou, Athanasios G.
    Kourounis, George
    Vagenakis, George A.
    FERTILITY AND STERILITY, 2007, 88 (05) : 1311 - 1317
  • [16] Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome
    Jap, T. -S.
    Chiu, C. -Y.
    Lirng, J. -F.
    Won, G. -S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (01) : 53 - 59
  • [17] A case of novel mutation in ANOS1 (KAL1) gene and review of Kallmann syndrome
    Arora, Sumeet
    Yeliosof, Olga
    Chin, Vivian L.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2023, 2023 (02):
  • [18] Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome
    T. S. Jap
    C. Y. Chiu
    J. F. Lirng
    G. S. Won
    Journal of Endocrinological Investigation, 2011, 34 : 53 - 59
  • [19] Point mutations in KAL1 and the mitochondrial gene MT-tRNAcys synergize to produce Kallmann syndrome phenotype
    Wang, Fei
    Huang, Guo-dong
    Tian, Hui
    Zhong, Ying-bin
    Shi, Hui-juan
    Li, Zheng
    Zhang, Xian-sheng
    Wang, Han
    Sun, Fei
    SCIENTIFIC REPORTS, 2015, 5
  • [20] Point mutations in KAL1 and the mitochondrial gene MT-tRNAcys synergize to produce Kallmann syndrome phenotype
    Fei Wang
    Guo-dong Huang
    Hui Tian
    Ying-bin Zhong
    Hui-juan Shi
    Zheng Li
    Xian-sheng Zhang
    Han Wang
    Fei Sun
    Scientific Reports, 5